VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NBY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NBYNovaBay Pharmaceuticals, Inc.
$1.47$9M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNBYPrice History

NBY logoNovaBay Pharmaceuticals, Inc. (NBY) Stock Price History

Historical prices from 2001 to 2026

$1.47+0.03  (+2.52%)close Jun 18
Returns
1M
—
3M
—
YTD
-95.8%
1Y
-84.1%
3Y
-75.2%
5Y
-79.7%
ATH$999,999.00Oct 2007-100.0%
ATL$1.00Jun 2026pre-split
Avg Vol (50D)132K/ day
52-Week Range$1.00 — $99.75
LowCurrent: $1.47High

Loading 10-year price history...

NBY Historical Performance

1 YearTotal Return
-84.1%
Price: -84.1%
3 YearsTotal Return
-93.5%
CAGR: -59.7%
Price: -98.5%
5 YearsTotal Return
-99.9%
CAGR: -72.9%
Price: -100.0%
YTD
-95.8%

NBY Annual Returns

Year-by-year price performance · 2002–2026

Best+928.8%2025
Worst-91.3%2023
Up years11/25
2002+0.0%
2003+0.0%
2004+0.0%
2005+0.0%
2006+0.0%
2007-42.4%
2008-73.3%
2009+102.0%
2010-17.8%
2011-19.8%
2012-15.0%
2013+8.8%
2014-51.2%
2015-87.4%
2016+63.4%
2017+18.8%
2018-81.2%
2019-35.4%
2020+11.5%
2021-48.5%
2022-86.0%
2023-91.3%
2024-91.2%
2025+801.0%
2026-95.0%
2002 annual price return
+0.0%
2003 annual price return
+0.0%
2004 annual price return
+0.0%
2005 annual price return
+0.0%
2006 annual price return
+0.0%
2007 annual price return
-42.4%
2008 annual price return
-73.3%
2009 annual price return
+102.0%
2010 annual price return
-17.8%
2011 annual price return
-19.8%
2012 annual price return
-15.0%
2013 annual price return
+8.8%
2014 annual price return
-51.2%
2015 annual price return
-87.4%
2016 annual price return
+63.4%
2017 annual price return
+18.8%
2018 annual price return
-81.2%
2019 annual price return
-35.4%
2020 annual price return
+11.5%
2021 annual price return
-48.5%
2022 annual price return
-86.0%
2023 annual price return
-91.3%
2024 annual price return
-91.2%
2025 annual price return
+801.0%
2026 annual price return
-95.0%
LessMore
Alpha vs S&P 500
1Y-99.1%
3Y-81.4%
5Y-85.5%

Price returns only.

Download Historical Data

6,367 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NBY Stock Price Trajectory (2001–2026)

As of October 3, 2026, NovaBay Pharmaceuticals, Inc. (NBY) trades at $1.47, representing a -84.1% return over the past year. The stock has delivered a -99.9% total return over five years (-79.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $999,999.00 on October 25, 2007. From this peak, NBY has corrected -100.0%, currently trading 85% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers AYTU (+5.1% 1Y), PRPH (-99.7% 1Y), and OGEN (-63.0% 1Y), NBY has underperformed the peer group average. Compare NBY vs AYTU →

NBY Historical Price Data · from 2001

Rows 1–50 of 6,367
Date Open High Low Close Volume Change %
2026-06-181.181.251.181.22132K+2.52%
2026-06-171.131.501.131.19463K+7.21%
2026-06-161.101.171.091.11150K+2.78%
2026-06-151.041.151.041.08159K+6.93%
2026-06-121.091.141.001.01615K-7.34%
2026-06-111.051.141.031.091.59M+1.87%
2026-06-101.071.111.031.0770K+2.88%
2026-06-091.151.161.041.04198K-10.34%
2026-06-081.191.211.131.1679K+3.57%
2026-06-051.201.251.111.1284K-7.44%
2026-06-041.181.271.151.21102K+4.31%
2026-06-031.141.171.101.1673K+0.87%
2026-06-021.131.161.081.15298K-4.96%
2026-06-011.231.301.171.21271K-4.72%
2026-05-291.331.361.251.27124K-3.05%
2026-05-281.361.421.291.31203K-6.43%
2026-05-271.251.421.231.40201K+6.87%
2026-05-261.331.391.251.31610K-7.09%
2026-05-221.541.541.411.415.24M-4.73%
2026-05-211.651.651.431.4855K-2.63%
2026-05-201.601.641.451.5299K-1.94%
2026-05-191.591.631.551.5555K-2.52%
2026-05-181.691.721.581.59110K-3.05%
2026-05-151.731.731.601.6470K0.00%
2026-05-141.841.841.621.64141K-7.87%
2026-05-131.741.791.691.7895K+2.30%
2026-05-121.651.881.651.74132K+5.45%
2026-05-111.671.901.621.65165K+1.23%
2026-05-081.581.671.481.63114K+6.54%
2026-05-071.651.651.511.5388K-7.27%
2026-05-061.481.651.401.65146K+15.38%
2026-05-051.331.461.291.4383K+9.16%
2026-05-041.361.451.311.31126K0.00%
2026-05-011.311.331.241.3153K+5.65%
2026-04-301.251.301.231.2458K-2.36%
2026-04-291.321.341.201.27125K+0.79%
2026-04-281.321.381.261.2655K-3.82%
2026-04-271.331.401.311.3168K-1.50%
2026-04-241.301.411.291.33126K+3.10%
2026-04-231.381.501.281.29110K-7.19%
2026-04-221.381.471.381.39147K+0.72%
2026-04-211.401.421.381.38171K-1.43%
2026-04-201.481.491.371.40162K-9.09%
2026-04-171.531.551.491.54121K+2.67%
2026-04-161.581.621.411.50181K-4.46%
2026-04-151.671.681.541.57294K-5.42%
2026-04-141.641.661.581.6678K+1.22%
2026-04-131.591.671.581.64103K+2.50%
2026-04-101.561.711.551.60425K+1.27%
2026-04-091.701.731.551.58187K-9.20%
…
Consensus & Technical Research Suite
Open NBY Terminal

NBY Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NBY — Frequently Asked Questions

Quick answers to the most common questions about buying NBY stock.

How has NBY stock performed recently?

NBY declined -84.1% over the past year, below its 5-year annualized CAGR of -79.7%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is NBY's all-time high price?

NovaBay Pharmaceuticals, Inc. reached $999999.00 on 2007-10-25. The 52-week high is $99.75. Current 1-year return of -84.1% places the stock further from historical peaks.

Where can I download NBY historical price data?

This page provides NBY daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2001-2026, downloadable in CSV format.

491 data points · sampled from 6,367